Evidence map›Paper›PMID 29602838›Full record

ArticleBMJ open2018

Measuring quality of life of people with predementia and dementia and their caregivers: a systematic review protocol.

Filipa Landeiro, Katie Walsh, Isaac Ghinai, Seher Mughal, Elsbeth Nye, Helena Wace, Nia Roberts, Pascal Lecomte, Raphael Wittenberg, Jane Wolstenholme and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Genomic and proteomic conversion of brain ischemia to Alzheimer's disease.Frontiers in cell and developmental biology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 5 countries.

Filipa LandeiroHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Katie WalshHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Isaac GhinaiHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Seher MughalHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Elsbeth NyeHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Helena WaceHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Nia RobertsBodleian Health Care Libraries, University of Oxford, Oxford, UK.
Pascal LecomteHealth Economic Modelling and Methodology, Novartis Pharma AG, Basel, Switzerland.
Raphael WittenbergPersonal Social Services Research Unit, London School of Economics and Political Science, London, UK.
Jane WolstenholmeHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Ron HandelsAlzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neurosciences, Maastricht University, Maastricht, The Netherlands.
Emilse Roncancio-DiazLife Sciences, GE Healthcare, Amersham, UK.
Michele H PotashmanValue and Access, Biogen, Cambridge, Massachusetts, USA.
Antje Tockhorn-HeidenreichGPORWE International, Eli Lilly and Company, Windlesham, UK.
Alastair M GrayHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID 0000-0003-0239-7278
ROADMAP Group
University of Oxford · GBBiogen (United States) · USEli Lilly (United Kingdom) · GBKarolinska Institutet · SELondon School of Economics and Political Science · GBNovartis (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDementia is the fastest growing major cause of disability globally and may have a profound impact on the health-related quality of life (HRQoL) of both the patient with dementia and those who care for them. This review aims to systematically identify and synthesise the measurements of HRQoL for people with, and their caregivers across the full spectrum of, dementia from its preceding stage of predementia to end of life. METHODS AND ANALYSIS: A systematic literature review was conducted in Medical Literature Analysis and Retrieval System Online , ExcerptaMedicadataBASE, Cochrane Database of Systematic Reviews , Cochrane Central Register of Controlled Trials, Database of Abstracts of Reviews of Effect, National Health Service Economic Evaluation Database and PsycINFO between January 1990 and the end of April 2017. Two reviewers will independently assess each study for inclusion and disagreements will be resolved by a third reviewer. Data will be extracted using a predefined data extraction form following best practice. Study quality will be assessed with the Effective Public Health Practice Project quality assessment tool. HRQoL measurements will be presented separately for people with dementia and caregivers by instrument used and, when possible, HRQoL will be reported by disease type and stage of the disease. Descriptive statistics of the results will be provided. A narrative synthesis of studies will also be provided discussing differences in HRQoL measurements by instrument used to estimate it, type of dementia and disease severity. ETHICS AND DISSEMINATION: This systematic literature review is exempt from ethics approval because the work is carried out on published documents. The findings of the review will be disseminated in a related peer-reviewed journal and presented at conferences. They will also contribute to the work developed in the Real World Outcomes across the Alzheimer's disease spectrum for better care: multimodal data access platform (ROADMAP). TRIAL REGISTRATION NUMBER: CRD42017071416.

Indexed as

CaregiversDementiaQuality of LifeHumansProspective StudiesRetrospective StudiesSystematic Reviews as Topicalzheimer’s diseasedementiaquality of lifesystematic literature reviewutility

Identifiers

PMID29602838
PMCPMC5884378
OpenAlexW2794843874

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.